cetylpyridinium chloride anhydrous has been researched along with Fatty Liver, Nonalcoholic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Hoyos, CM; Jun, JC; Kim, D; Mokhlesi, B; Pamidi, S | 1 |
| Auwerx, J; Cialabrini, L; De Franco, F; de Seigneux, S; Gariani, K; Giacchè, N; Ivanisevic, J; Katsyuba, E; Legouis, D; Liscio, P; Matilainen, O; Mottis, A; Pellicciari, R; Raffaelli, N; Ryu, D; Schoonjans, K; Stokar-Regenscheit, N; van der Velpen, V; Zietak, M | 1 |
| Baek, KH; Kang, MI; Kim, MK; Kim, SW; Lee, WY; Oh, KW; Park, CY; Park, SE; Park, SW; Rhee, EJ | 1 |
| Anderson, A; Chen, YD; Haffner, SM; Hairston, KG; Lorenzo, C; Montez, M; Norris, JM; Samaropoulos, XF; Scherzinger, AL; Wagenknecht, LE | 1 |
| Finkelstein, J; Heemels, MT; Shadan, S; Weiss, U | 1 |
| Arciello, M; Balsano, C; Barbaro, B; Galli, A; Maggio, R; Tarocchi, M; Toietta, G | 1 |
| Miyazawa, T; Yanagita, T | 1 |
| Baccan, GC; Marcos, A; Nova, E; Veses, A; Zapatera, B | 1 |
| Blomme, B; Caron, S; Colle, I; Coulon, S; De Munter, S; Francque, S; Geerts, A; Heindryckx, F; Prawitt, J; Staels, B; Van Gaal, L; Van Vlierberghe, H; Verrijken, A | 1 |
2 review(s) available for cetylpyridinium chloride anhydrous and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Effects of the olive-derived polyphenol oleuropein on human health.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Health; Humans; Iridoid Glucosides; Iridoids; Lipid Metabolism; Non-alcoholic Fatty Liver Disease; Olea; Polyphenols; Protective Agents | 2014 |
Potential health benefits of moderate alcohol consumption: current perspectives in research.
Topics: Alcohol Drinking; Animals; Cardiovascular Diseases; Cause of Death; Ethanol; Fatty Liver; Health; Humans; Immune System; Inflammation; Insulin Resistance; Neoplasms; Non-alcoholic Fatty Liver Disease | 2012 |
7 other study(ies) available for cetylpyridinium chloride anhydrous and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Editorial: Metabolic Health in Normal and Abnormal Sleep.
Topics: Energy Metabolism; Health; Humans; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Risk Factors; Sleep; Sleep Apnea, Obstructive; Sleep Deprivation | 2020 |
De novo NAD
Topics: Animals; Caenorhabditis elegans; Carboxy-Lyases; Cell Line; Choline; Conserved Sequence; Disease Models, Animal; Evolution, Molecular; Female; Gene Knockdown Techniques; Health; Hepatocytes; Homeostasis; Humans; Kidney; Liver; Longevity; Male; Methionine; Mice; Mice, Inbred C57BL; Mitochondria; NAD; Non-alcoholic Fatty Liver Disease; Rats; Sirtuins | 2018 |
High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome.
Topics: Adult; Aged; Calcifediol; Cross-Sectional Studies; Fatty Liver; Health; Humans; Male; Metabolic Syndrome; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Republic of Korea; Risk Factors; Young Adult | 2013 |
A metabolically healthy obese phenotype in hispanic participants in the IRAS family study.
Topics: Abdominal Fat; Adult; Body Fat Distribution; Cardiovascular Diseases; Cohort Studies; Female; Health; Hispanic or Latino; Humans; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Overweight; Phenotype; Prevalence; Radiography; United States; Young Adult | 2013 |
Lipids in health and disease.
Topics: Adipose Tissue; Fatty Acids, Omega-3; Fatty Liver; Health; Humans; Lipid Metabolism; Metabolic Diseases; Non-alcoholic Fatty Liver Disease; Sphingolipids | 2014 |
Lipid Nutrition and Healthy Aging.
Topics: Aging; Animals; Carotenoids; Diet; Dietary Fats; Health; Humans; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Obesity | 2015 |
Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.
Topics: Adult; Angiogenesis Inducing Agents; Biopsy; Case-Control Studies; Fatty Liver; Female; Gene Expression Regulation; Health; Humans; Inflammation; Interleukin-6; Linear Models; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2; Young Adult | 2012 |